Archived documents

Documents past their public comment period for Healthcare & Public Health.

FDAOther

Formal Meetings Between the Food and Drug Administration and Sponsors or Applicants of Prescription Drug User Fee Act Products; Draft Guidance for Industry

13 comments · 8 awaiting analysis

Net support +40% across analyzed comments

Top issues in comments

Not yet determined
Read the record →Closes Dec 22
FDANotice

Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List Additions and Request for Comments

12 comments · 11 awaiting analysis

Net support 0% across analyzed comments

Top issues in comments

Not yet determined
Read the record →
VANPRM

Expanding Access to State Prescription Drug Monitoring Programs (AS73)

11 comments

Net support +36% across analyzed comments

Top issues in comments

  • Immigration enforcement fee amount
Read the record →
FDANotice

Fiscal Year 2026 Generic Drug Science and Research Initiatives Workshop; Public Workshop; Request for Comments

9 comments · 4 awaiting analysis

Net support +80% across analyzed comments

Top issues in comments

  • Independent batch testing
  • Nitrosation reaction rate
  • Pediatric drug development
Read the record →
FDAOther

Acute Radiation Syndrome: Developing Drugs for Prevention and Treatment; Guidance for Industry; Draft Guidance

8 comments · 7 awaiting analysis

Net support -100% across analyzed comments

Top issues in comments

Not yet determined
Read the record →Closes Jul 20
FDANotice

Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey

8 comments · 8 awaiting analysis

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
CDCRule

Control of Communicable Diseases; Foreign Quarantine

8 comments

Net support -50% across analyzed comments

Top issues in comments

  • Travel restrictions effectiveness
  • Equitable public health policies
  • Public health evidence
Read the record →
FDAOther

Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-inHuman (FIH) Trials; Guidance for Industry; Draft Guidance

6 comments · 5 awaiting analysis

Net support 0% across analyzed comments

Top issues in comments

Not yet determined
Read the record →Closes Jul 25
CDCNotice

Extended Evaluation of the National Tobacco Prevention and Control Public Education Campaign 2026-07761

6 comments

Net support +100% across analyzed comments

Top issues in comments

  • Support for campaign evaluation
Read the record →
CDCNotice

Order Under Sections 362 and 365 of the Public Health Service Act Continuing the Suspension of the Right To Introduce Certain Persons From Countries Where a Quarantinable Communicable Disease Exists

5 comments

Net support -100% across analyzed comments

Top issues in comments

  • Agency jurisdiction and expertise
  • Lpr travel status
Read the record →
CMSProposed Rule

CY 2027 Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates. CMS-1850-P Display

5 comments

Net support -60% across analyzed comments

Top issues in comments

  • Asc reimbursement rates
  • Device-intensive designation
  • Missing records as mismatches
Read the record →
FAANotice

Agency Information Collection Activities; Proposals, Submissions, and Approvals: Medical Standards and Certification

4 comments

Net support +75% across analyzed comments

Top issues in comments

  • Form 8500-8 question 18v
Read the record →